603 related articles for article (PubMed ID: 21504839)
41. Targeting gene-virus-mediated manganese superoxide dismutase effectively suppresses tumor growth in hepatocellular carcinoma in vitro and in vivo.
Huang F; Ma B; Wang Y; Xiao R; Kong Y; Zhou X; Xia D
Cancer Biother Radiopharm; 2014 Dec; 29(10):403-11. PubMed ID: 25414976
[TBL] [Abstract][Full Text] [Related]
42. Aptamer-mediated gene therapy enhanced antitumor activity against human hepatocellular carcinoma in vitro and in vivo.
Xiao S; Liu Z; Deng R; Li C; Fu S; Chen G; Zhang X; Ke F; Ke S; Yu X; Wang S; Zhong Z
J Control Release; 2017 Jul; 258():130-145. PubMed ID: 28522194
[TBL] [Abstract][Full Text] [Related]
43. Antitumor activity of an hTERT promoter-regulated tumor-selective oncolytic adenovirus in human hepatocellular carcinoma.
Su CQ; Wang XH; Chen J; Liu YJ; Wang WG; Li LF; Wu MC; Qian QJ
World J Gastroenterol; 2006 Dec; 12(47):7613-20. PubMed ID: 17171789
[TBL] [Abstract][Full Text] [Related]
44. The adenovirus-mediated linamarase/linamarin suicide system: a potential strategy for the treatment of hepatocellular carcinoma.
Li J; Li H; Zhu L; Song W; Li R; Wang D; Dou K
Cancer Lett; 2010 Mar; 289(2):217-27. PubMed ID: 19733963
[TBL] [Abstract][Full Text] [Related]
45. Survivin knockdown by short hairpin RNA abrogates the growth of human hepatocellular carcinoma xenografts in nude mice.
Zhang R; Ma L; Zheng M; Ren J; Wang T; Meng Y; Zhao J; Jia L; Yao L; Han H; Li K; Yang A
Cancer Gene Ther; 2010 Apr; 17(4):275-88. PubMed ID: 19876077
[TBL] [Abstract][Full Text] [Related]
46. Oncolytic virotherapy for osteosarcoma using midkine promoter-regulated adenoviruses.
Takagi-Kimura M; Yamano T; Tagawa M; Kubo S
Cancer Gene Ther; 2014 Mar; 21(3):126-32. PubMed ID: 24577130
[TBL] [Abstract][Full Text] [Related]
47. A novel oncolytic adenovirus based on simian adenovirus serotype 24.
Cheng T; Song Y; Zhang Y; Zhang C; Yin J; Chi Y; Zhou D
Oncotarget; 2017 Apr; 8(16):26871-26885. PubMed ID: 28460470
[TBL] [Abstract][Full Text] [Related]
48. Hepatocellular carcinoma-targeting oncolytic adenovirus overcomes hypoxic tumor microenvironment and effectively disperses through both central and peripheral tumor regions.
Yoon AR; Hong J; Kim M; Yun CO
Sci Rep; 2018 Feb; 8(1):2233. PubMed ID: 29396500
[TBL] [Abstract][Full Text] [Related]
49. Potent antitumor efficacy of an E1B 55kDa-deficient adenovirus carrying murine endostatin in hepatocellular carcinoma.
Li G; Sham J; Yang J; Su C; Xue H; Chua D; Sun L; Zhang Q; Cui Z; Wu M; Qian Q
Int J Cancer; 2005 Feb; 113(4):640-8. PubMed ID: 15389517
[TBL] [Abstract][Full Text] [Related]
50. Triple-controlled oncolytic adenovirus expressing melittin to exert inhibitory efficacy on hepatocellular carcinoma.
Qian CY; Wang KL; Fang FF; Gu W; Huang F; Wang FZ; Li B; Wang LN
Int J Clin Exp Pathol; 2015; 8(9):10403-11. PubMed ID: 26617748
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of twenty-one human adenovirus types and one infectivity-enhanced adenovirus for the treatment of malignant melanoma.
Hoffmann D; Bayer W; Heim A; Potthoff A; Nettelbeck DM; Wildner O
J Invest Dermatol; 2008 Apr; 128(4):988-98. PubMed ID: 17960177
[TBL] [Abstract][Full Text] [Related]
52. An oncolytic adenovirus regulated by a radiation-inducible promoter selectively mediates hSulf-1 gene expression and mutually reinforces antitumor activity of I131-metuximab in hepatocellular carcinoma.
Zhang Y; Fang L; Zhang Q; Zheng Q; Tong J; Fu X; Jiang X; Su C; Zheng J
Mol Oncol; 2013 Jun; 7(3):346-58. PubMed ID: 23182495
[TBL] [Abstract][Full Text] [Related]
53. Antitumoural immunity by virus-mediated immunogenic apoptosis inhibits metastatic growth of hepatocellular carcinoma.
Boozari B; Mundt B; Woller N; Strüver N; Gürlevik E; Schache P; Kloos A; Knocke S; Manns MP; Wirth TC; Kubicka S; Kühnel F
Gut; 2010 Oct; 59(10):1416-26. PubMed ID: 20675696
[TBL] [Abstract][Full Text] [Related]
54. Toxicology profiles of a novel p53-armed replication-competent oncolytic adenovirus in rodents, felids, and nonhuman primates.
Su C; Cao H; Tan S; Huang Y; Jia X; Jiang L; Wang K; Chen Y; Long J; Liu X; Wu M; Wu X; Qian Q
Toxicol Sci; 2008 Nov; 106(1):242-50. PubMed ID: 18703561
[TBL] [Abstract][Full Text] [Related]
55. Engineered measles virus as a novel oncolytic viral therapy system for hepatocellular carcinoma.
Blechacz B; Splinter PL; Greiner S; Myers R; Peng KW; Federspiel MJ; Russell SJ; LaRusso NF
Hepatology; 2006 Dec; 44(6):1465-77. PubMed ID: 17133484
[TBL] [Abstract][Full Text] [Related]
56. Mesenchymal stem cells deliver and release conditionally replicative adenovirus depending on hepatic differentiation to eliminate hepatocellular carcinoma cells specifically.
Yuan X; Zhang Q; Li Z; Zhang X; Bao S; Fan D; Ru Y; Dong S; Zhang Y; Zhang Y; Ye Z; Xiong D
Cancer Lett; 2016 Oct; 381(1):85-95. PubMed ID: 27450327
[TBL] [Abstract][Full Text] [Related]
57. Enhanced gene transfer and oncolysis of head and neck cancer and melanoma cells by fiber chimeric oncolytic adenoviruses.
Reddy PS; Ganesh S; Yu DC
Clin Cancer Res; 2006 May; 12(9):2869-78. PubMed ID: 16675583
[TBL] [Abstract][Full Text] [Related]
58. E1A, E1B double-restricted adenovirus with RGD-fiber modification exhibits enhanced oncolysis for CAR-deficient biliary cancers.
Wakayama M; Abei M; Kawashima R; Seo E; Fukuda K; Ugai H; Murata T; Tanaka N; Hyodo I; Hamada H; Yokoyama KK
Clin Cancer Res; 2007 May; 13(10):3043-50. PubMed ID: 17505007
[TBL] [Abstract][Full Text] [Related]
59. Conditionally replicative adenovirus vector carrying TRAIL gene for enhanced oncolysis of human hepatocellular carcinoma.
Ye X; Lu Q; Zhao Y; Ren Z; Ren XW; Qiu QH; Tong Y; Liang M; Hu F; Chen HZ
Int J Mol Med; 2005 Dec; 16(6):1179-84. PubMed ID: 16273304
[TBL] [Abstract][Full Text] [Related]
60. A novel bladder cancer - specific oncolytic adenovirus by CD46 and its effect combined with cisplatin against cancer cells of CAR negative expression.
Cao W; Tian J; Li C; Gao Y; Liu X; Lu J; Wang Y; Wang Z; Svatek RS; Rodriguez R
Virol J; 2017 Aug; 14(1):149. PubMed ID: 28789701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
